Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) expressed a positive opinion by recommending the approval of BRAFTOVI ® (encorafenib) together with MEKTOVI...

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Endomagnetics Ltd (Endomag), a privately held UK-based developer of breast...

Alphatec Holdings, Inc.a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery,announced the commercial launch of EOS Insight, a groundbreaking, end-to-end...

MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the recently published results of the CLinical EValuation of WEB 17 Device in...

Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)™ solutions, is thrilled to announce the launch of its latest innovative product: the first cellular-connected,...

Preterm birth (PTB) is a poorly-noticed crisis impacting millions of families worldwide. Defined as delivery before 37 weeks of gestation, PTB is the most prevalent, devastating, and expensive...

The molecular design strategy and experimental results of Bright Gene's dual GLP-1/GIP receptor agonist, BGM0504, have been published online in Scientific Reports, a sub-journal of Nature, on July...

SHINE Technologies, a next-generation fusion company, will showcase FLARE™, the world's most powerful continuous fusion neutron system, at the IEEE Nuclear & Space Radiation Effects and at the...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the launch of a new sprinkle formulation of INGREZZA® (valbenazine) capsules, the #1 prescribed vesicular monoamine transporter 2 (VMAT2)...

Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on validated targets in cancer and inflammatory diseases,...

Cytonics Corporation, a private biotechnology company developing biologic therapies for musculoskeletal ailments, announced initiation of enrollment for its Phase 1 clinical study of...

Oticon Medical announced the U.S. Food and Drug Administration (FDA) clearance of its first active transcutaneous bone conduction hearing system, the Sentio System. Sentio System delivers the proven...